Inhibikase Therapeutics, Inc. (IKT) has 12 identified peers for comparison in the Healthcare sector. Peers include ANEB, ANTX, DMAC, KLDO, LGVN, LIFE and others.
IKT has a market capitalization of $120.71M, compared to an average peer market cap of $165.33M.
